Search Orphan Drug Designations and Approvals
-
Generic Name: | Synthetic porcine secretin | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Secreflo | ||||||||||||||||
Date Designated: | 06/18/1999 | ||||||||||||||||
Orphan Designation: | For use in the evaluation of exocrine pancreas function. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
ChiRhoClin, Inc. 15500 Gallaudet Ave. Silver Spring, Maryland 20905 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Synthetic porcine secretin |
---|---|---|
Trade Name: | Secreflo | |
Marketing Approval Date: | 11/01/2002 | |
Approved Labeled Indication: | For use in secretin stimulation testing for: Stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangio-pancreatography (ERCP) | |
Exclusivity End Date: | 11/01/2009 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-